The global polycystic ovary syndrome (PCOS) market is anticipated to grow at a modest CAGR of around 4.0% during the forecast period (2021-2027). PCOS is an endocrine disorder found in women of childbearing age (ages 15 to 44) which affects their hormone levels. Women with PCOS produce higher-than-normal amounts of male hormones. This hormone imbalance causes their body to skip menstrual periods and makes it harder for them to get pregnant. In PCOS women’s ovaries, the reproductive organs that produce estrogen and progesterone are affected majorly. Diuretics, Insulin Sensitizing Agents, Antiandrogens, and Oral Contraceptive Pills are some of the major drugs used in the diagnosis of PCOD disorder.
To Request a Sample of our Report on Polycystic Ovary Syndrome (PCOS) Market: https://www.omrglobal.com/request-sample/polycystic-ovary-syndrome-pcos-market
The changing lifestyles, rising obesity in women, and increasing cases of hormonal imbalances in women are the factors that contributed to the rise in the incidence of PCOS. According to the Centres for Disease Control and Prevention, approximately 5 million women of reproductive age suffer from the polycystic ovarian syndrome. Additionally, according to the International Journal of Reproduction, Contraception, Obstetrics, and Gynecology, a study was conducted on 170 women of reproductive age, in which 70 women were affected with PCOS which was 41%, in which 16% were married women and 24% in unmarried women with PCOS. Obesity in women is another major factor that increases the chances of PCOS. Thus, the high prevalence is accelerating market growth.
However, factors such as side effects coupled with PCOS drugs such as weight gain, unwanted hair growth, increase insulin resistance, cardiovascular risks, and thromboembolic events are hindering the growth of the market. Further, the advancements in PCOS is also accelerating the market growth, For instance, in February 2020, Ava, a digital healthcare company focused on women’s reproductive health, announced that it had received clearance approval from FDA for its Ava Fertility Tracker, a wearable fertility tracking sensor bracelet and accompanying app. The device aid women in ovulation prediction and facilitation of conception.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Drug Type
- By Diagnosis Type
- By Treatment Type
- By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Abbott Laboratories, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Co., Ferring Pharmaceuticals, Merck & Co., Inc.., Novartis AG, Teva Pharmaceutical Industries Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Polycystic Ovary Syndrome (PCOS) Market is Available at: https://www.omrglobal.com/industry-reports/polycystic-ovary-syndrome-pcos-market
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global PCOS Market Report Segment
By Drug Type
- Diuretics
- Insulin Sensitizing Agents
- Antiandrogens
- Anti-Depressants
- Ornithine Decarboxylase Inhibitors
- Anti-Obesity
- Oral Contraceptive Pills
By Diagnosis Type
- Ultrasound
- Pelvic Exam
- Blood Test
- By Treatment Type
- Ovarian Wedge Resection
- Laparoscopic Ovarian Drilling
- Acupuncture
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies (Online and Offline)
- Fertility Clinics
Global PCOS Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of The World
- Latin America
- Middle East & Africa
Company Profiles
- Abbott Laboratories
- Astellas Pharma Inc.
- AstraZeneca plc
- AVA Science Inc.
- Bayer AG
- Bristol-Myers Squibb Co.
- Dexa Medica (Dexa Group)
- Ferring B.V.
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Millendo Therapeutics, Inc.
- MyOva
- Novartis AG
- PCOS Diva LLC
- Pharmasure Ltd.
- Sanofi SA
- Sneha Natura
- Teva Pharmaceutical Industries Ltd.
- The Himalaya Drug Co.
- Theralogix, LLC
Reasons to Buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/polycystic-ovary-syndrome-pcos-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
